XML 53 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - EUR (€)
€ in Thousands
Total
Kreos share warrants
Other equity agreement
SHARE CAPITAL
SHARE CAPITAL
Kreos share warrants
SHARE CAPITAL
Other equity agreement
PREMIUMS RELATED TO SHARE CAPITAL
PREMIUMS RELATED TO SHARE CAPITAL
Kreos share warrants
TRANSLATION RESERVE
RETAINED EARNINGS
NET LOSS FOR THE YEAR
Number of shares issued at beginning of period (in shares) at Dec. 31, 2021 16,764,051                    
Reconciliation of number of shares outstanding [abstract]                      
Capital increase from issuance of ordinary shares (in shares) 5,530,000                    
Exercises of share warrants (in shares) 19,134                    
Number of shares issued at end of period (in shares) at Dec. 31, 2022 22,313,185                    
Equity at beginning of period at Dec. 31, 2021 € 25,934     € 168     € 107,578   € 0 € (39,361) € (42,452)
Changes in equity [abstract]                      
Net loss for the period (60,740)                   (60,740)
Other comprehensive income (loss) 235                 235  
Total comprehensive income (loss) for the period (60,506)                 235 (60,740)
Appropriation of prior period net loss 0                 (42,452) 42,452
Capital increase from issuance of ordinary shares 46,231     55     46,176        
Transaction costs related to capital increase (3,280)           (3,280)        
Exercises of share warrants 3           2        
Shares based compensation expense (1,164)                 (1,164)  
Transaction on treasury shares (28)                 (28)  
Equity at end of period at Dec. 31, 2022 € 7,189 [1]     223     150,476   0 (82,770) (60,740)
Reconciliation of number of shares outstanding [abstract]                      
Capital increase from issuance of ordinary shares (in shares) 40,325,500                    
Exercises of share warrants (in shares)   99,583 190,550                
Number of shares issued at end of period (in shares) at Dec. 31, 2023 62,928,818                    
Changes in equity [abstract]                      
Net loss for the period € (147,740)                   (147,740)
Other comprehensive income (loss) 225               112 112  
Total comprehensive income (loss) for the period (147,516)               112 112 (147,740)
Appropriation of prior period net loss 0                 (60,740) 60,740
Capital increase from issuance of ordinary shares 353,377     403     352,974        
Transaction costs related to capital increase (28,111)           (28,111)        
Issue of convertible notes 1,030           1,030        
Exercises of share warrants   € 1,850 € 2   € 1 € 2   € 1,849      
Shares based compensation expense 8,179                 8,179  
Transaction on treasury shares 10                 10  
Equity at end of period at Dec. 31, 2023 € 196,010 [1]     629     478,218   112 (135,209) (147,740)
Reconciliation of number of shares outstanding [abstract]                      
Exercises of share warrants (in shares) 4,000   4,000                
Issue of free shares (in shares) 415,019                    
Number of shares issued at end of period (in shares) at Dec. 31, 2024 63,347,837                    
Changes in equity [abstract]                      
Net loss for the period € (176,242)                   (176,242)
Other comprehensive income (loss) (219)               (187) (31)  
Total comprehensive income (loss) for the period (176,461)               (187) (31) (176,242)
Appropriation of prior period net loss 0                 (147,740) 147,740
Transaction costs related to capital increase 446           446        
Issue of share warrants 200           200        
Exercises of share warrants 45           45        
Issue of free shares 1     4     (4)        
Shares based compensation expense 20,224                 20,224  
Transaction on treasury shares 120                 120  
Equity at end of period at Dec. 31, 2024 € 40,584     € 633     € 478,905   € (75) € (262,637) € (176,242)
[1] 1In application of the Amendments to IAS 1 Presentation of Financial Statements – Classification of Liabilities as Current or Non-current, and
Non-current Liabilities with Covenants, the non-current portion of the OCEANE bonds as of December 31, 2022, amounting to €19,332
thousand, and the non-current portion of the Heights convertible notes as of December 31, 2023, amounting to €20,652 thousand, were
reclassified within the current liabilities (Convertible loan notes) as of December 31, 2022 and 2023 respectively (see Note 2).